Loading...
By Kelly Young
Edited by David G. Fairchild, MD, MPH, and Jaye Elizabeth Hefner, MD
Screening for type 2 diabetes does not appear to reduce mortality risk, but treating adults with impaired glucose tolerance (IGT) or impaired fasting glucose (IFG) could have other benefits, according to a systematic review conducted for the U.S. Preventive Services Task Force and published in the Annals of Internal Medicine.
In two randomized trials, screening for diabetes had no effect on mortality after 10 years' follow-up. However, in 16 studies, lifestyle and drug interventions appeared to delay or prevent incident diabetes in patients who were overweight or obese and had IFG or IGT.
In October, the USPSTF released draft recommendations stating that high-risk adults should be screened for type 2 diabetes and insulin resistance. Final recommendations have not yet been released.
Comment
LINK(S):
Annals of Internal Medicine article (Free abstract)
Background: Physician's First Watch coverage of USPSTF draft recommendation on screening for type 2 diabetes (Free)